ANGO ANGIODYNAMICS INC
ANGIODYNAMICS INC (ANGO) news
ANGIODYNAMICS INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ANGO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest ANGIODYNAMICS INC news
We have not published a story on ANGIODYNAMICS INC yet. When there is news, it will appear here.
ANGIODYNAMICS INC annual financials
| Line | FY ended May 31, 2026 | FY ended May 31, 2025 |
|---|---|---|
| Research and development | $29.4 million | $26.2 million |
| Net income (loss) | -$36.7 million | -$34.0 million |
| Cash from operations | $3.1 million | -$10.1 million |
| Cash and equivalents | $53.9 million | $55.9 million |
Questions about ANGIODYNAMICS INC
What is the ticker symbol of ANGIODYNAMICS INC?
ANGIODYNAMICS INC trades under the ticker ANGO on NASDAQ.
Where is ANGIODYNAMICS INC listed?
ANGIODYNAMICS INC is listed on NASDAQ.
Which country or territory is ANGIODYNAMICS INC listed under?
Our directory records ANGIODYNAMICS INC under United States.
Does aibio.space cover ANGIODYNAMICS INC?
aibio.space lists ANGIODYNAMICS INC among 2,820 public biotech companies and publishes its news here as stories appear.
Is ANGIODYNAMICS INC profitable?
ANGIODYNAMICS INC reported a net loss of $36.7 million for the fiscal year ended May 31, 2026, and generated $3.1 million of cash from operations, per its annual report to the SEC.
How much does ANGIODYNAMICS INC spend on research and development?
$29.4 million in the fiscal year ended May 31, 2026, per its annual report.
How much cash does ANGIODYNAMICS INC have?
$34.0 million in cash at Aug 31, 2026, per its 10-Q.
Investor discussion: ANGIODYNAMICS INC
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- ANGIODYNAMICS INC
- Ticker
- ANGO
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio